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Abstract Our think tank tasked by the Dutch Health
Council, consisting of Radboud University Nijmegen
Honours Academy students with various backgrounds,
investigated the implications of Deep Brain Stimulation
(DBS) for psychiatric patients. During this investiga-
tion, a number of methodological, ethical and societal
difficulties were identified. We consider these difficul-
ties to be a reflection of a still fragmented field of
research that can be overcome with improved organiza-
tion and communication. To this effect, we suggest that
it would be useful to found a centralized DBS organiza-
tion. Such an organization makes it possible to 1) set up
and maintain a repository, 2) facilitate DBS studies with
a larger sample size, 3) improve communication
amongst researchers, clinicians and ethical committees,
and 4) improve communication between DBS experts
and the public at large.
Keywords DeepBrain Stimulation . Repository .
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The Health Council of the Netherlands asked the think
tank ‘Wider Implications of Cognitive Neuroscience’ of
the Radboud University Nijmegen Honours Academy
to investigate the implications of Deep Brain
Stimulation (DBS) for psychiatric patients. The think
tank consisted of a team of master students with back-
grounds in various disciplines: philosophy, behavioral
science, political science, medicine, and economics. In
this brief communiqué, we present the outcomes of our
investigation – not as categorical statements, but as the
suggestions of a group of aspiring scientists that took a
fresh look at this relatively new, important, and rapidly
developing research area.1 The main conclusion of our
report is that the establishment of a centralized organi-
zation of DBS experts is an important first step in
Neuroethics (2015) 8:187–190
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1 In this article we are only able to give a partial summary of the
entire report. For a more thorough discussion, see our full report
[23].
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addressing a number of methodological, ethical, and
societal issues surrounding DBS. We will discuss four
advantages of such an organization: a prospect of setting
up and maintaining a repository, facilitating studies with
a larger sample size, improving communication
amongst researchers, clinicians and ethical committees,
and improving communication between DBS experts
and the public at large. We will end by arguing why
existing organizations do not yet appear to be up to this
task.
Investigations of DBS as a treatment for psychiatric
disorders are still at an early stage. Currently, only
treatment-refractory psychiatric patients are allowed
DBS-treatment, which in turn results in small sample
sizes [e.g., [1]]. Small sample sizes are customary dur-
ing early phases of clinical trials [2]. For invasive treat-
ments, these early phases often comprise samples of
patients that are treatment-refractory. Because of the
ethical concerns surrounding invasive techniques for
non-neurodegenerative psychiatric illnesses,2 small
sample trials may turn out to remain the status quo.
Unfortunately, due to these small sample sizes, crucial
control conditions are often missing. As the field may
suffer from fragmentation due tomany small studies, the
creation of a repository has been proposed by numerous
authors [3–6]. We were not able, however, to find any
evidence for the existence of such a repository or its
development. An important incentive for establishing a
centralized organization is that setting up and monitor-
ing a repository is no small feat and requires a coordi-
nation of efforts that existing (local) organizations may
not be able to provide.
Additional benefits of a repository include transpar-
ency and the facilitation of communication between
research groups. Transparency may be especially impor-
tant due to possible conflicts of interests that may arise
due to investment from a relatively small number of
commercial companies in research [7]. Lastly, another
benefit of a repository is being able to find
(unpublished) null results; important in itself but even
more crucial in the field of DBSwhere decisions need to
be made about which patient groups are the most likely
candidates to receive DBS.
Establishing and maintaining a repository is one way
to mitigate the problem of small sample sizes. However,
a centralized organization could mitigate the problem of
small sample sizes in a second way. Instead of relying
on multiple small studies that each employ slightly
different methods, a number of (international) research
groups may come together and set up larger multicenter
studies of efficacy with a standardized research method-
ology. Setting up such large-scale studies not only re-
quires plentiful resources but also a large and well-
functioning infrastructure. A centralized organization
could be able to provide this.
Aside from the methodological issues discussed
above, the use of DBS faces a number of particularly
unique ethical challenges. Some examples are personal-
ity or identity changes [8–13], informed consent [8, 14],
and the use of DBS for enhancement [15]. Such ethical
challenges require debate as well as expert guidance,
both of which can be facilitated by establishing expert
ethical committees (ECs) committed to including DBS
experts. Regular ethical committees may not be suffi-
ciently specialized in the aforementioned ethical chal-
lenges unique to DBS. An expert EC could advise
university and institute ECs on the peculiarities and
specificities of DBS research. A second role of an expert
ECmay be in advising hospitals and institutes regarding
eligible patient groups. The proposed centralized orga-
nization could house such an expert EC and provide it
with a communication infrastructure.
The general public is mostly informed of DBS
through the media. The media, however, often portrays
DBS too optimistically [16–18]. This bias may have
both large- and small-scale implications. On the larger
scale, the public may develop a distorted understanding
of the technique, its purpose, its applications, and its
effects. Such a distorted understanding may lead to a
diminished public awareness of the technique, its uses,
its risks, and its consequences. On the smaller scale, as
patients often turn to the media to educate themselves
about their condition and possible treatments [19, 20],
theymay already have a positively-biased opinion of the
use of DBS before coming into contact with a clinician.
It is of great importance to establish a continuous
dialogue between those working in the field of DBS and
the general public. Such a dialogue may serve to inform
2 Generally, later stages could comprise larger groups of patients.
For example, DBS has seen moderate success in the larger patient
population with early indications of Parkinson’s Disease [24] and
Alzheimer’s Disease [25]. However, it is debatable whether the
use of DBS for neurodegenerative illnesses such as Parkinson’s is
comparable to the use of DBS for non-neurodegenerative psychi-
atric illnesses. While Parkinson’s disease inevitably reaches the
point of being untreatable, this is not the case for all psychiatric
illnesses. As such, an ethical question that arises is whether an
invasive technique such as DBS should be tested on psychiatric
patients who have noninvasive treatment options left.
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the general public about the current state of the art in
order to create realistic expectations regarding the effi-
cacy of DBS. Additionally, it may facilitate better-
informed ethical debate in the public sphere, for exam-
ple, by organizing conferences for journalists, creating a
website containing up-to-date information, and devel-
oping standardized communication procedures for re-
searchers and research institutes for contact with the
media. As this is a demanding task, a centralized orga-
nization could prove useful in realizing these kinds of
implementations.
We mentioned above the benefit for communication
by establishing a repository. It is worth noting that
providing data and articles in a repository is a form of
passive communication: people who are interested are
able to look up relevant information. However, in addi-
tion to passive communication we argue for the facili-
tation of active communication, as it is important to
keep relevant parties informed of new developments.
Currently, this is partly achieved by DBS-specific and
more general neurostimulation conferences. A central-
ized organization could facilitate the application of such
active communication efforts by providing the neces-
sary infrastructure.
As the topics we have discussed in this paper illus-
trate, many of the issues concerning DBS are the result
of – in itself understandable – small-scale studies, lead-
ing to a fragmentation of the field and a lack of coherent
communication between DBS experts and a wider au-
dience. Due to the negative consequences of fragmen-
tation, as discussed above, it is of importance that an
organization encompasses all of the roles we have iden-
tified. These roles include maintaining a repository,
housing an expert ethical committee, creating infrastruc-
ture for multicenter studies, facilitating communication
among researchers and between researchers and the
general public.While there are a number of international
DBS organizations, these organizations are neither as
specialized nor as all-inclusive as we would recom-
mend. For example, the Dana Foundation’s mission
states: BThe Dana Foundation is committed to advanc-
ing brain research and to educating the public in a
responsible manner about the potential of research^
[21]. While this mission is close to our recommenda-
tions – concerning communication between profes-
sionals and the general public – this organization is not
specialized to the extent of being able to, for example,
provide an expert ethical committee or govern a repos-
itory. Another example would be the European
Association of Neurosurgical Societies (EANS) [22].
While the EANS is specialized and invested in neuro-
surgery, neurotechnology is a specialization in its own
right. Additionally, the EANS is less concerned with
communication between experts and the general popu-
lation than we see as necessary. A possible solution
would be for one of the existing organizations to incor-
porate the responsibilities we identified but moves to-
wards this are not yet being carried out. Another possi-
bility is to form a completely new organization, prefer-
ably funded by international, governmental institutions
like the European Union and supervised by a board of
leading experts.
In conclusion, as young developing scientists new to
the field, we present our observations as mere sugges-
tions that, hopefully, are of interest to the experts. We
neither have the experience nor the affiliations required
to found the suggested organization, however to stimu-
late the debate we have identified a number of issues
pertaining to the fragmentation of the field of DBS. We
suggest that there is a need for a centralized organization
as an important first step in reducing fragmentation in
order to alleviate the methodological, ethical, and soci-
etal problems that DBS gives rise to.
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